Even resurrected, the dog adds no warmth, insight, or narrative purpose to Meghan’s new ‘With Love’ special. Any editor could have removed it in seconds. That they did not is the point. European ...

YouTuber SteveWillDoIt clashed with Logan Paul on the Impaulsive podcast after labeling MrBeast 'fake' and claiming he was abandoned during a YouTube ban. Steve's erratic behavior, including insults ...

Defense Secretary Pete Hegseth “does not know” who the military is killing in strikes against “drug boats” off the coast of Venezuela, a report has alleged. People familiar with classified briefings ...

The Beast in Me is a psychological thriller limited series that was released on Netflix on November 13, 2025. The series features Claire Danes as Aggie Wiggs, a mourning author. She visits her rich ...

We may know when to expect the next stages of the DCU. Netflix’s Assassin’s Creed show has found its star. Matthew Lillard hypes up Mike Flanagan’s Carrie. Plus, one more look at the final season of ...

Laura Walls does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

In The Beast in Me, Aggie Wiggs (Claire Danes) is a reclusive writer who gets drawn into the world of her new neighbour, Nile Jarvis (Matthew Rhys), a narcissistic and possibly psychopathic ...

This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 3 minutes Tiny power banks that barely ...

The Beast in Me is the Netflix chilling thriller that has kept surprising its viewers with every twist. The show tells the story of Nile Jarviz, a property tycoon who was once the prime suspect behind ...

The second season of MrBeast's record-setting Prime Video reality competition show will have a "strong vs. smart" theme when it returns in 2026. By Alex Weprin Senior Editor MrBeast‘s record-setting ...

After laying off 80% of staffers this spring, Tempest Therapeutics is acquiring several CAR-T programs from Factor Bioscience and bringing the latter’s CEO on board to helm the company. The asset ...